Diabetes drug may reduce risk of developing Parkinson's disease

New study in humans appears to confirm what has been shown in animal studies that a class of drug used to treat diabetes may reduce the risk of developing Parkinson's disease.

The researchers found a 28% lower incidence of Parkinson's disease in the patients taking glitazones compared with counterparts taking other treatments for diabetes. The finding did not change when they took into account other factors that might affect Parkinson's disease risk - including smoking and head injury.

Original source


Register for receiving PharmaAround news, register for PharmAround events.
Continue registration